Deepthi Ramesh, PhD, MSc
Postdoctoral Scholar
Pharmaceutical Chemistry
School of Pharmacy

Education & Training

Show all (1) Hide

• PhD Medicinal chemistry Pondicherry University

Interests

Show all (1) Hide

• Organic chemistry Medicinal chemistry

Websites

Show all (1) Hide

• LinkedIn (linkedin.com)

Publications (12)

Top publication keywords:
ChitosanNucleotidesTuberculosisIndolesMolecular Docking SimulationHepatitis, Viral, HumanChalconesUracilEnzyme InhibitorsStructure-Activity RelationshipLeishmania donovaniAntiprotozoal AgentsAntitubercular AgentsNucleosidesLeishmaniasis

• Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin-mediated vesicular trafficking pathway.
  Archiv der Pharmazie 2024 Thottasseri AA, Kaur G, Ramesh D, Banerjee I, Kannan T
• Enhancing antifungal properties of chitosan by attaching isatin-piperazine-sulfonyl-acetamide pendant groups via novel imidamide linkage.
  International journal of biological macromolecules 2023 Gowrivel Vijayakumar B, Ramesh D, Kumari S, Maity A, Pinnaka AK, Kannan T
• Uracil derivatives as HIV-1 capsid protein inhibitors: design, in silico, in vitro and cytotoxicity studies.
  RSC advances 2022 Ramesh D, Mohanty AK, De A, Vijayakumar BG, Sethumadhavan A, Muthuvel SK, Mani M, Kannan T
• Chitosan with pendant (E)-5-((4-acetylphenyl)diazenyl)-6-aminouracil groups as synergetic antimicrobial agents.
  Journal of materials chemistry. B 2022 Vijayakumar BG, Ramesh D, Santhosh Manikandan K, Theresa M, Sethumadhavan A, Priyadarisini VB, Radhakrishnan EK, Mani M, Kannan T
• Acetylene containing 2-(2-hydrazinyl)thiazole derivatives: design, synthesis, and in vitro and in silico evaluation of antimycobacterial activity against Mycobacterium tuberculosis.
  RSC advances 2022 Maganti LHB, Ramesh D, Vijayakumar BG, Khan MIK, Dhayalan A, Kamalraja J, Kannan T

Show all (7 more) Hide

• Erratum: First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
  Archiv der Pharmazie 2022 Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, Vijayakumar BG, Chatterjee M, Sriram D, Muthuvel SK, Kannan T
• First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
  Archiv der Pharmazie 2022 Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, G Vijayakumar B, Chatterjee M, Sriram D, Muthuvel SK, Kannan T
• Frontiers in Clinical Drug Research: Anti-Infectives
  Therapeutic Targets for Emerging Zika Virus Infection and Vaccines in Clinical Trials 2021 Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan
• Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections.
  ChemMedChem 2021 Ramesh D, Vijayakumar BG, Kannan T
• Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders.
  European journal of medicinal chemistry 2020 Ramesh D, Vijayakumar BG, Kannan T
• In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
  European journal of pharmacology 2020 Vijayakumar BG, Ramesh D, Joji A, Jayachandra Prakasan J, Kannan T
• Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
  European journal of medicinal chemistry 2020 Ramesh D, Joji A, Vijayakumar BG, Sethumadhavan A, Mani M, Kannan T